Part of a Collection


This report provides insights into China’s healthcare tech market, delving into the latest news on government initiatives, industry dynamics, and macro environment trends.

The rise of Chinese medtech

Rapid growth has been seen in Chinese medtech companies in recent years

Medtech Insight is about to release its 2021 list of the World’s Top 100 Medtech Companies (publicly owned) based on revenue. The number of Chinese companies in the top 100 increased from four in 2020 to six in 2021, and is expected to further grow to eight in 2022.

A closer look at the top 10 Chinese medtech companies shows a strong compound annual growth rate (CAGR) of 28% as a whole between 2019 and 2021—far above their international counterparts.